Abirateron-Teva 500 mg, Filmtabletten - 56 Swissmedic Key 68319001 Registration Holder Teva Pharma AG Name Abirateron-Teva 500 mg, Filmtabletten Date of registration 02.05.2022 Original/Generic Generic Introduction of Sequence 02.05.2022 ATC-Classification Abiraterone (L02BX03) Revision date WHO WHO-DDD Valid until 01.05.2027 Index Therapeuticus (BSV) 07.16.20. Show package size 56 Index Therapeuticus (Swissmedic) 07.16.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 897.80 Limitation Yes Limitation text
Deductible 10 % Consumer price 1047.20 Feedback FB Daily cost GTIN 7680683190019 Medication Code Synthetika Pharmacode Disponibility
Composition abirateroni acetas 500 mg corresp. abirateronum 446.0 mg, lactosum monohydricum 90 mg, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 9.96 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Abirateroni Acetas 500 mg correspond Abirateronum 446 mg
BAG: Active Agent Dose Abirateroni Acetas 500 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Lactose Monohydrate 90 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Povidonum K 30 Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 04.06.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
